Researchers from Kyoto University and RIKEN, led by Osamu Takeuchi and Takuhiro Ito, have uncovered a previously unrecognized layer of genetic regulation involving a protein called DHX29. This protein is pivotal in identifying and silencing less efficient genetic instructions, revealing that not all synonymous codons are treated equally by the cellular machinery. The study highlights how cells can selectively suppress non-optimal codons, which are associated with weaker mRNA stability and translation efficiency.

The findings underscore the significance of codon choice in gene expression regulation. Through genome-wide CRISPR screening, the team identified DHX29’s role in the selective degradation of mRNAs that contain non-optimal codons. When DHX29 is absent, these less efficient mRNAs accumulate, indicating that DHX29 actively participates in maintaining cellular balance by ensuring that only optimal genetic messages are translated into proteins. The interaction of DHX29 with the 80S ribosome and its recruitment of the GIGYF2•4EHP complex further elucidate the mechanism by which cells manage codon efficiency.

This discovery has broad implications for the field of gene regulation and could shift current paradigms in research related to cell differentiation, cancer development, and other biological processes. Understanding the DHX29-mediated control of mRNA stability may accelerate drug development timelines by providing new targets for therapeutic intervention in diseases linked to gene expression dysregulation. As research continues, the potential to leverage this mechanism for enhancing healthspan and longevity becomes increasingly tangible.

Source: sciencedaily.com